Intragenic deletion of TRIM32 in compound heterozygotes with sarcotubular myopathy/LGMD2H

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Kristian Borg - , Karolinska Institutet (Autor:in)
  • Rolf Stucka - , Ludwig-Maximilians-Universität München (LMU) (Autor:in)
  • Matthew Locke - , Cardiff University, University of Oxford (Autor:in)
  • Eva Melin - , Karolinska Institutet (Autor:in)
  • Gabrielle Åhlberg - , Karolinska Institutet (Autor:in)
  • Ursula Klutzny - , Ludwig-Maximilians-Universität München (LMU) (Autor:in)
  • Maja Von Der Hagen - , Klinik und Poliklinik für Kinder- und Jugendmedizin, Abteilung für Neuropädiatrie (Autor:in)
  • Angela Huebner - , Klinik und Poliklinik für Kinder- und Jugendmedizin (Autor:in)
  • Hanns Lochmüller - , Newcastle University (Autor:in)
  • Klaus Wrogemann - , University of Manitoba (Autor:in)
  • Lars Eric Thornell - , Umeå University (Autor:in)
  • Derek J. Blake - , Cardiff University (Autor:in)
  • Benedikt Schoser - , Ludwig-Maximilians-Universität München (LMU) (Autor:in)

Abstract

In 2005 the commonality of sarcotubular myopathy (STM) and limb girdle muscular dystrophy type 2H (LGMD2H) was demonstrated, as both are caused by the p D487N missense mutation in TRIM32 originally found in the Manitoba Hutterite population. Recently, three novel homozygous TRIM32 mutations have been described in LGMD patients. Here we describe a three generation Swedish family clinically presenting with limb girdle muscular weakness and histological features of a microvacuolar myopathy. The two index patients were compound heterozygotes for a frameshift mutation in TRIM32 (c.1560delC ) and a 30 kb intragenic deletion, encompassing parts of intron 1 and the entire exon 2 of TRIM32. In these patients, no full-length or truncated TRIM32 could be detected. Interestingly, heterozygous family members carrying only one mutation showed mild clinical symptoms and vacuolar changes in muscle. In our family, the phenotype encompasses additionally a mild demyelinating polyneuropathic syndrome. Thus STM and LGMD2H are the result of loss of function mutations that can be either deletions or missense mutations.

Details

OriginalspracheEnglisch
Seiten (von - bis)E831-E844
FachzeitschriftHuman mutation
Jahrgang30
Ausgabenummer9
PublikationsstatusVeröffentlicht - Sept. 2009
Peer-Review-StatusJa

Externe IDs

PubMed 19492423

Schlagworte

ASJC Scopus Sachgebiete

Schlagwörter

  • LGMD2H, Muscular dystrophy, Sarcotubular myopathy, TRIM32